PARRA, G. A.; LINDARTE, H. H.; RUBIO, A. F. Over optimum response to PCSK-9 inhibitors: ¿is it mandatory to supply them every 2 weeks?, about a case. Revista Colombiana de Endocrinología, Diabetes & Metabolismo, [S. l.], v. 7, n. 1, p. 43–44, 2020. DOI: 10.53853/encr.7.1.568. Disponível em: https://revistaendocrino.org/index.php/rcedm/article/view/568. Acesso em: 28 apr. 2026.